AAAAAA

   
Results: 1-3 |
Results: 3
A PHASE I II EVALUATION OF ORAL L-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACIDIN ASYMPTOMATIC PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/
Authors: BARDITCHCROVO P NOE D SKOWRON G LEDERMAN M KALAYJIAN RC BORUM P BUIER R ROWE WB GOLDBERG D LIETMAN P
Citation: P. Barditchcrovo et al., A PHASE I II EVALUATION OF ORAL L-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACIDIN ASYMPTOMATIC PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/, Journal of clinical pharmacology, 38(4), 1998, pp. 357-363
APPARENT DEFICIENCY OF GLUTATHIONINE IN THE PBMCS OF PEOPLE WITH AIDSDEPENDS ON METHOD OF EXPRESSION
Authors: BARDITCHCROVO P SVOBODOVA V LIETMAN P
Citation: P. Barditchcrovo et al., APPARENT DEFICIENCY OF GLUTATHIONINE IN THE PBMCS OF PEOPLE WITH AIDSDEPENDS ON METHOD OF EXPRESSION, Journal of acquired immune deficiency syndromes and human retrovirology, 8(3), 1995, pp. 313-314
A RANDOMIZED TRIAL OF THE ACTIVITY AND SAFETY OF RO-24-7429 (TAT ANTAGONIST) VERSUS NUCLEOSIDE FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: HAUBRICH RH FLEXNER C LEDERMAN MM HIRSCH M PETTINELLI CP GINSBERG R LIETMAN P HAMZEH FM SPECTOR SA RICHMAN DD HAMMER S COOLEY T GULICK R SULLIVAN M SPINA C FRASER A LATHEY J BASSIAKOS Y CHANCE M DROBNES C CORUELL E GRUE L RAINES C KUWAHARA S MCPHERSON J
Citation: Rh. Haubrich et al., A RANDOMIZED TRIAL OF THE ACTIVITY AND SAFETY OF RO-24-7429 (TAT ANTAGONIST) VERSUS NUCLEOSIDE FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The Journal of infectious diseases, 172(5), 1995, pp. 1246-1252
Risultati: 1-3 |